Pfizer Inc. today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide ...

Life Extension shares a variety of winter vitamins, supplements, and tips to help the body during the cold season.

Drawing from personal experience, Patty Keating advocates for greater awareness, improved diagnosis, and treatment among ...